Watch Video
Share
January 2, 2023
In this episode of Behind the Bell, Acrivon Therapeutics Founder, President and CEO Peter Blume-Jensen gives advice to aspiring entrepreneurs, speaks to the role Acrivon Therapeutics is playing in paving the way for the new era of precision medicine, and how being Nasdaq-listed is making it all possible.
Watch more of Behind the Bell on Nasdaq.com: nasdaq.com/news-and-insights/behind-the-bell
#nasdaq #stockmarket #stocks #finance #financial #trading #trader #stock
Posts